SL-251131
SL-251131 is a reversible non-specific MAO inhibitor. SL-251131 temporarily blocks both MAO-A and MAO-B enzymes, which are responsible for breaking down neurotransmitters like dopamine. SL-251131 can be used for the study of Parkinson's disease[1].
Product Specifications
CAS Number
176773-86-7
UNSPSC
12352005
Target
Monoamine Oxidase
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Smiles
O=C1N2C3=CC=C(OCCCC(F)(F)F)C=C3CC[C@@]2([H])[C@H](O1)COC
Molecular Formula
C17H20F3NO4
Molecular Weight
359.34
References & Citations
[1]Korczyn AD, Nussbaum M. Emerging therapies in the pharmacological treatment of Parkinson’s disease. Drugs. 2002 Apr;62 (5) :775-86.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
QP10290-ec-250ug 250ug
Recombinant Rat Cxcl17 Protein, Untagged, E.coli-250ug
Sign In for Pricing
View Details bs-11961R-BF594 100 µL
SNAIL + SLUG Polyclonal Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details 
K3020802 1.0 µg DNA
Duox2 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
TL706667V 500 µL Each
Mtmr2 Rat shRNA Lentiviral Particle (Locus ID 315422)
Sign In for Pricing
View Details 